The glucose reading can be shared with physicians via the LibreLinkUp mobile app. Credit: Niek Verlaan / Pixabay.

Health Canada has approved Abbott’s sensor-based glucose monitoring technology, FreeStyle Libre 2, for adults and children aged four and above with diabetes.

The system continuously measures glucose levels every minute with customisable, optional real-time alarms to alert users of critical events like hypoglycemia (low glucose levels) and hyperglycemia (high glucose levels).

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Eliminating the need for painful fingersticks, the wearable technology delivers accurate and actionable information to people with diabetes and enables better management of their condition.

Abbott Canada diabetes care business general manager Marie-Flore Nabor said: “For the millions of Canadians with diabetes, Abbott’s next-generation FreeStyle Libre 2 system expands on the life-changing capabilities of our original FreeStyle Libre system with enhanced accuracy, optional alarms and now available for children.

“This latest technology will transform the way diabetes is currently managed. The FreeStyle Libre 2 is designed to simplify this often complicated-to-manage condition and is accessible and affordable to people with diabetes in Canada.”

With the help of Bluetooth technology, the system alerts users on high or low glucose levels without scanning the sensor, Abbott noted.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Worn on the back of the upper arm for up to 14 days, the FreeStyle Libre 2 sensor measures glucose levels.

Users can check their glucose reading, trend arrow, and eight-hour history with a one-second scan using FreeStyle LibreLink app or handheld reader.

The reading can be shared with physicians through the LibreLinkUp mobile app.

The system uses the same wired enzyme technology and price range of the FreeStyle Libre system, which was the first to remove painful fingersticks.

Abbott’s FreeStyle Libre 2 system will be made available to over 3.7 million Canadians with diabetes soon.